Technology With Actionable Results

Bioarray Genetics patented intelligent gene profiling platform leverages unique RNA biomarkers, phenotypic signatures and proprietary algorithms to provide distinct valuable information about patient response to oncology drugs. The platform, which is based on a panel of genes that has minimal overlap with other commercial and research gene panels, provides novel insight for the development of analytical tools, predictive tests and companion diagnostics.

Bioarray applies its state-of-the art platform to analyze the expression levels of multiple genes across multiple pathways and translates extensive amounts of genomic data into actionable information.  The platform has been verified in the most common cancer types including lung, colorectal, breast, prostate and ovarian cancer.

Contact Bioarray at to learn more about the power of our technology.